RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $181
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh maintains an Outperform rating on Johnson & Johnson and raises the price target from $178 to $181.
October 16, 2024 | 12:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reaffirmed its Outperform rating on Johnson & Johnson and increased the price target from $178 to $181, indicating positive expectations for the stock.
The increase in price target from $178 to $181 by RBC Capital suggests a positive outlook for Johnson & Johnson's stock. The Outperform rating indicates that the analyst expects the stock to perform better than the market average, which could lead to a short-term increase in stock price as investors react to the updated target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100